Financhill
Back

Cellectar Biosciences Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLRB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Cellectar Biosciences Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.28 Buy
20-day SMA: 0.31 Sell
50-day SMA: 0.31 Sell
200-day SMA: 1.32 Sell
8-day EMA: 0.28 Buy
20-day EMA: 0.26 Buy
50-day EMA: 0.17 Buy
200-day EMA: 0.06 Buy

Cellectar Biosciences Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 49.27 Sell
Chaikin Money Flow: 226267 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.27 - 0.37) Sell
Bollinger Bands (100): (0.04 - 0.9) Sell

Cellectar Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cellectar Biosciences Stock

Is Cellectar Biosciences Stock a Buy?

CLRB Technical Analysis vs Fundamental Analysis

Sell
22
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy or a Sell?

Cellectar Biosciences Stock Info

Market Cap:
13.8M
Price in USD:
0.30
Share Volume:
226.3K

Cellectar Biosciences 52-Week Range

52-Week High:
3.51
52-Week Low:
0.22
Sell
22
Cellectar Biosciences (CLRB) is a Sell

Cellectar Biosciences Share Price Forecast

Is Cellectar Biosciences Stock a Buy?

Fundamental Analysis of Cellectar Biosciences

Is Cellectar Biosciences a good investment?

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.93 per share, and a decrease next year of $0.21 per share.

Technical Analysis of Cellectar Biosciences

Should I short Cellectar Biosciences stock?

* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.